North America is expected to be the most opportunistic Live Cell RNA Detection market, expanding at a 35.0% share

Global Live Cell RNA Detection Market demand is anticipated to be valued at US$ 2,631.8 Million in 2022, forecast to grow at a CAGR of 8.4% to be valued at US$ 6,404.2 Million from 2022 to 2032. RNA plays an important role in cell and tissue development as well as disease progression thus it is …

Humanised Mouse Model Market Forecast to 2032 | By Axenis, Trans Genic, Genoway, Vitalstar Biotechnology

In 2022, the global humanised mouse model market is anticipated to be worth US$ 92.5 million. Throughout the decade 2022 to 2032, the industry is expected to grow at a 5.5% CAGR to reach US$ 167.3 Million. Rising healthcare industry need for more active screening of innovative drug candidates identified to cure a variety of …

Oxygen Therapy Equipment Market is expected to reach a valuation of US$ 6.4 Billion by 2032 | FMI Study

The Oxygen Therapy Equipment Market is projected to grow at a CAGR of 7.4% between 2022 and 2032. From US$ 3.1 billion in 2022, the market for oxygen therapy equipment is projected to grow to US$ 6.4 billion in 2032. “Over the forecast period, the demand is expected to be driven by the rising popularity …

Veterinary Molecular Diagnostics Market totaling around US$ 352.8 Million by 2032

[275 Page Document] In 2022, the market for veterinary molecular diagnostics is projected to be worth US$182.1 million. The overall demand for veterinary molecular diagnostics is anticipated to increase at a CAGR of 6.84% between 2022 and 2032, reaching a total of about US$ 352.8 Million by 2032 due to the adoption of multiple testing …

Next Generation Immunotherapies Market to expand at a 7.5% value CAGR by 2033

The global next generation immunotherapies market is estimated to exceed a spectacular valuation of US$ 268.84 billion in 2033, with a compound annual growth rate (CAGR) of 7.5% projected from 2023 to 2033. The vast majority of present immunotherapies, such as checkpoint inhibitors, seek to enhance the immune system’s adaptive response, precisely cytotoxic T cells, in order …

Multiplex Biomarker Imaging Market is expected to reach US$ 1,041.7 Million by 2029

[Report of 280 Pages] The global Multiplex Biomarker Imaging Market was valued at US$ 422.1 Mn in 2021 and is expected to reach US$ 1,041.7 Mn by 2029, finds Future Market Insights (FMI) in a recent market survey. As per the findings of the report, the global multiplex biomarker imaging market is projected to experience significant growth …

Monkeypox Treatment Market is expected to reach a valuation of US$ 93.84 million in 2023

The market for monkeypox medications is anticipated to be worth US$ 93.84 million in 2023 and US$ 249 million by 2033, expanding at a CAGR of 10.25% over the forecast period. During the forecast period, it is anticipated that demand for efficient treatments, vaccines, and other therapeutics for rare diseases will drive market growth. A …

Opioid Use Disorder Treatment Market is projected to reach US$ 8.4 billion by 2033

The global opioid use disorder treatment market size is expected to attain an impressive valuation of US$ 3.07 billion in 2023 and is projected to reach US$ 8.4 billion by 2033, expanding at a CAGR of 10.5% during the forecast period. The drug abuse treatment providers and manufacturers primarily focus on creating awareness among people and drug …

Pharmaceutical Filtration Market to reach a valuation of ~US$ 41.0 Billion by 2032

The global pharmaceutical filtration market is expected to enjoy a valuation of US$ 17.8 Bn by the end of 2022 and further expand at a CAGR of 8.7% to reach a valuation of ~US$ 41.0 Bn by 2032. According to the recent study, membrane filters segment by product is leading the market with a share of about 33.3% in 2021. Active pharmaceutical ingredients are a …

Animal Healthcare Market is expected to surpass US$ 62.3 billion by 2033

The market for animal healthcare is anticipated to reach a value of US$ 40.9 billion in 2023 and US$ 62.3 billion by 2033. During the forecast period, animal healthcare sales are anticipated to increase significantly at a CAGR of 4.3%. There are several factors driving the demand for animal healthcare, including: The global animal healthcare market was …